From Biomarkers to Companion Diagnostics: Advances in Immuno-Oncology Clinical Trial Assay Development, New Webinar Hosted by Xtalks

Share Article

In immuno-oncology, companion diagnostics are used in conjunction with targeted drugs and therapies to identify patients who are likely to benefit from a specific treatment regimen or who may have increased risk for certain side effects.

Xtalks Life Science Webinars

This live webinar will have two broadcasts at 9am EST (2pm GMT) and 2pm EST.

The featured speakers will examine the integration of digital pathology, clinical trial design and tissue-based testing solutions for biomarker validation to quickly advance immuno-oncology therapies to pivotal clinical trial-scale studies. Join Steven Anderson, Ph.D., Chief Scientific Officer at Covance Drug Development, and Gillian Livock, Vice President of Corporate Business Development at Definiens on Tuesday, January 22, 2019.

To learn more about this complimentary event visit: From Biomarkers to Companion Diagnostics: Advances in Immuno-Oncology Clinical Trial Assay Development.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Candice Tang
Xtalks
+1 416 977 6555
Email >
Visit website